Skip to main content

Shobha Parthasarathi, Rob Lindberg, Rathindra Bose, David Ramsay

Shobha Parthasarathi has joined the North Carolina Biotechnology Center as technology development director in NCBC’s Business and Technology Development unit.  
Parthasarathi was previously a senior researcher and manager at Millennium Pharmaceuticals, where she conducted drug discovery research, evaluated technologies, and developed in-house expertise for multiple therapeutic groups.
Parthasarathi succeeds Rob Lindberg, who has become director of the NCBC’s Business Acceleration & Technology Out-licensing Network, or BATON, program.

Ohio University has named Rathindra Bose as its new vice president for research and creative activity and dean of the graduate college. Bose will begin work July 1.
Bose is currently vice president for research and dean of the graduate school at Northern Illinois University. He was previously vice president for research and dean of graduate studies at Kent State University.
Bose will manage the university's new graduate college and research division, which includes offices that oversee the university's external grants and contracts, research compliance, grant writing, research communication, technology transfer, and economic development functions.

David Ramsay, president of the University of Maryland, Baltimore, was among several winners of the 2008 Greater Baltimore Region Bioscience Awards announced this week.
Ramsay, the recipient of the President’s Award, has “championed the growth of biomedical research and technology transfer at UMB, where biotech research has grown by 500 percent since 1994,” the Greater Baltimore Committee said in a statement.
Ramsay has also been leading development of the UMB BioPark in west Baltimore, which has grown to 340,000 square feet of research space and created 200 biotech jobs over the last five years, the committee said.

The Scan

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.